BioPharm News

Nov 13, 2017
By BioPharm International Editors
The companies have established a joint laboratory to develop full continuous processing to manufacture high yields of monoclonal antibodies at reduced costs.
Nov 13, 2017
By BioPharm International Editors
Alcami will manufacture clinical supply of the API for a drug candidate targeting various hematologics and solid cancers.
Nov 13, 2017
By BioPharm International Editors
Company completes first successful run of what is believed to be the largest synthesis-scale done for oligonucleotide APIs.
Nov 13, 2017
By BioPharm International Editors
The company has appointed Albert Bourla, PhD, as its new COO.
Nov 13, 2017
By BioPharm International Editors
Bormioli Rocco Pharma offers new packaging solutions for powdered oral drugs, parenteral drugs, pediatric syrups, and protein-based drugs.
Nov 10, 2017
By BioPharm International Editors
The authors of the study believe it could have significant implications for the discovery of new dermatological products for major diseases such as psoriasis.
Nov 10, 2017
By BioPharm International Editors
The company expects to commercially launch the new vaccine in the US in the first quarter of 2018.
Nov 10, 2017
By BioPharm International Editors
The company has introduced two new GMP vessel streams at its API manufacturing facility in Northumberland, UK that allows it to now offer fully integrated drug substance and drug product manufacturing.
Nov 10, 2017
By BioPharm International Editors
The EMA’s Committee for Medicinal Products for Human Use has recommended marketing authorization approval for AstraZeneca’s benralizumab, a monoclonal antibody for treating severe asthma.
Nov 10, 2017
By BioPharm International Editors
QuintilesIMS has changed its name to IQVIA to reflect its October 2016 merger with IMS Health.
native1_300x100
lorem ipsum